1. Association of polymorphisms in the Cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications;Aithal;Lancet,1999
2. Factor IX and thrombosis;Aledort;Scandinavian Journal of Haematology,1977
3. Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K;Anderson;Acta Medica Scandanavia,1975
4. Beriplex HS 250. Beriplex HS 500. Paul-Ehrlich-Institut (PEI);Arzneimittelkommission der deutschen Arzteschaft;Deutsches Arzteblatt,1994
5. Decentralised anticoagulant care;Baglin;Journal of Clinical Pathology,1998